A Phase I clinical study evaluating the safety, tolerability, pharmacokinetics, pharmacodynamics, and food effects of THDBH110 capsules in healthy Chinese adult subjects after single and multiple administrations.
Latest Information Update: 14 Nov 2025
At a glance
- Drugs THDBH 110 (Primary)
- Indications Type 2 diabetes mellitus
- Focus Adverse reactions
- Sponsors Tonghua Dongbao Pharmaceutical
Most Recent Events
- 14 Nov 2025 New trial record